vaccine stock 結果共2筆

This year’s flu season during the Lunar New Year has been relatively mild, potentially due to higher flu vaccination rates and continued mask-wearing, according to Philip Lo, the Deputy Director-General and spokesperson for the Centers for Disease Control (CDC). Typically, flu cases surge before and after the Lunar New Year, with the second day of the new year being the busiest for emergency rooms. Despite higher numbers in recent years, this year’s figures are considered mild compared to the pre-pandemic period. On the second day of the Lunar New Year, 6,787 individuals sought emergency care for flu-like symptoms. In previous years, the corresponding numbers were 4,313 in 2023, 1,564 in 2022, 2,458 in 2021, 9,240 in 2020, and 7,983 in 2019. Lo emphasized the need to monitor the potential impact of large gatherings as schools reopen and the travel season begins. In terms of vaccine stock, there are still 82,000 doses of the flu vaccine available, along with 226,000 doses of the Novavax COVID-19 vaccine and 4.38 million doses of the Moderna COVID-19 vaccine. Lo urged eligible individuals to get vaccinated promptly to enhance their protection.

The Taiwan FactCheck Center has clarified that MVC’s quadrivalent influenza vaccine is produced by the reputable South Korean pharmaceutical firm GC Biopharma, which has WHO qualification and is marketed in multiple countries. Additionally, the FactCheck Center noted that MVC’s method of vaccine production is not unprecedented, as other domestic manufacturers have also imported foreign vaccine stock solutions for local assembly.